THERAVECTYS
LIVE

Serial Number

79427841

Owner

THERAVECTYS

Attorney

Joseph Sofer

Filing Date

May 15, 2025

Add to watchlist:

No watchlists yet
View on USPTO

THERAVECTYS Trademark

Serial Number: 79427841 • Registration: 8182382

THERAVECTYS is a trademark filed by THERAVECTYS on May 15, 2025. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals), Class 40 (Treatment & Processing), Class 42 (Computer & Scientific), Class 44 (Medical Services). The application is currently registered and active.

Owner Contact Info

THERAVECTYS (5 trademarks)

28 rue du Docteur Roux,

Entity Type: 99

Trademark Details

Filing Date

May 15, 2025

Registration Date

March 24, 2026

Published for Opposition

February 3, 2026

Goods & Services

Scientific research for medical purposes; research and development services for pharmaceutical preparations; conducting clinical trials in the nature of scientific research; clinical research for scientific purposes; conducting scientific feasibility studies and analyses; biological, biotechnological, biochemical, medical and pharmaceutical research and development services for third parties; evaluation of the efficacy of pharmaceutical products.

Pharmaceutical and veterinary preparations for the treatment of cancer, infectious diseases and emerging infectious diseases; vaccines; pharmaceutical preparations containing lentiviral vectors for medical, pharmaceutical and veterinary use, particularly for the treatment of cancer, infectious diseases and emerging infectious diseases; chemical, biological and pharmaceutical preparations for therapeutic, medical, pharmaceutical and veterinary use, particularly for the treatment of cancer, infectious diseases and emerging infectious diseases; diagnostic preparations for therapeutic, medical and veterinary use; chemical reagents for medical or veterinary use.

Chemical preparations for use in industry and science; chemical preparations for scientific use, other than for medical or veterinary use; biological preparations for use in industry and science; chemical reagents other than for medical or veterinary use; chemical preparations for analyses in laboratories other than for medical or veterinary use; diagnostic preparations other than for medical or veterinary use; lentiviral vectors for scientific research.

Medical analysis and medical diagnosis services for the treatment of cancer, infectious diseases and emerging infectious diseases; medical analyses of blood samples; medical assistance services relating to medicine and health care; provision of medical information.

Pharmaceutical product custom manufacturing to order for third parties; vaccine manufacturing services to order for third parties.

Filing History

FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Jun 24, 2026 FICR
NOTICE OF REGISTRATION CONFIRMATION EMAILED
Mar 24, 2026 NRCC
REGISTERED-PRINCIPAL REGISTER
Mar 24, 2026 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Feb 3, 2026 NPUB
PUBLISHED FOR OPPOSITION
Feb 3, 2026 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jan 28, 2026 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Jan 8, 2026 CNSA
EXAMINER'S AMENDMENT ENTERED
Jan 8, 2026 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Jan 8, 2026 GNEN
EXAMINERS AMENDMENT E-MAILED
Jan 8, 2026 GNEA
EXAMINERS AMENDMENT -WRITTEN
Jan 8, 2026 CNEA
TEAS/EMAIL CORRESPONDENCE ENTERED
Jan 6, 2026 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jan 6, 2026 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jan 6, 2026 TROA
REFUSAL PROCESSED BY IB
Dec 11, 2025 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Nov 26, 2025 RFCS
REFUSAL PROCESSED BY MPU
Nov 26, 2025 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Oct 10, 2025 RFCR
NON-FINAL ACTION WRITTEN
Oct 9, 2025 CNRT
ASSIGNED TO EXAMINER
Sep 28, 2025 DOCK
APPLICATION FILING RECEIPT MAILED
Jul 18, 2025 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jul 18, 2025 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Jul 17, 2025 REPR